Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Sangustop® as Haemostatic Agent Versus a Carrier-bound Fibrin Sealant During Liver Resection (ESSCALIVER)

NCT00918619 is registered in ClinicalTrials.gov with Aesculap AG as lead sponsor.

NCT NCT00918619
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00918619 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Sangustop® as Haemostatic Agent Versus a Carrier-bound Fibrin Sealant During Liver Resection (ESSCALIVER)
Lead sponsor
Aesculap AG
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2010
Completion date
January 31, 2011
Enrollment
128 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

hemostasis, liver surgery